Novo Nordisk launches smart insulin pen in Denmark
Pharmaceutical company Novo Nordisk sends its smart insulin pens Novopen 6 and Novo Pen Echo Plus on the Danish market two months after they were launched in Sweden.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY CATHERINE BRETT AND NIELSINE NIELSEN
Two months after Novo Nordisk relaunched the firm's smart insulin pens Novopen 6 and Echo Plus in Sweden, they've made their way to the Danish market, according to a Danish press announcement from Novo Nordisk.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.